Ziegler Capital Management’s Quest Diagnostics DGX Stock Holding History

Ziegler Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.85M	Sell	13,955 -612	-4%	-$79.4K	0.07%	220
2023 Q4	$2.02M	Sell	14,567 -500	-3%	-$65.7K	0.09%	222
2023 Q3	$1.84M	Buy	15,067 +2,211	+17%	+$295K	0.07%	220
2023 Q2	$1.81M	Buy	12,856 +49	+0.4%	+$6.75K	0.07%	237
2023 Q1	$1.82M	Sell	12,807 -336	-3%	-$48.1K	0.07%	228
2022 Q4	$2.03M	Sell	13,143 -147	-1%	-$21.1K	0.09%	215
2022 Q3	$1.64M	Sell	13,290 -772	-5%	-$102K	0.07%	221
2022 Q2	$1.87M	Buy	14,062 +407	+3%	+$55.5K	0.08%	220
2022 Q1	$1.87M	Buy	13,655 +270	+2%	+$37.6K	0.08%	216
2021 Q4	$2.2M	Sell	13,385 -1,174	-8%	-$179K	0.08%	218
2021 Q3	$2.11M	Sell	14,559 -6,369	-30%	-$932K	0.08%	230
2021 Q2	$2.76M	Buy	+20,928	New	+$2.74M	0.09%	233

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ziegler Capital Management's DGX Position: Q1 2024 in Review

Ziegler Capital Management reduced its Quest Diagnostics (DGX) stake by 4.2% in Q1 2024, selling an estimated $79.4K and leaving 13,955 shares worth $1.85M. The position accounts for 0.07% of the portfolio, ranked #220.

Ziegler Capital Management first reported a position in DGX in Q2 2021 and has held it in 12 quarters since. The position peaked at $2.76M in Q2 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

Ziegler Capital Management held 13,955 shares of Quest Diagnostics worth $1.85M as of Q1 2024.
Ziegler Capital Management sold 612 Quest Diagnostics shares in Q1 2024, an estimated $79.4K.
Quest Diagnostics made up 0.07% of Ziegler Capital Management's portfolio in Q1 2024, its #220 holding.
Ziegler Capital Management first reported a position in Quest Diagnostics in Q2 2021 and has held it in 12 quarters since.
Ziegler Capital Management's Quest Diagnostics position peaked at $2.76M in Q2 2021.
819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.